Bill

Bill > H2286


MA H2286

MA H2286
To reduce fraud in prescription drug abuse testing and help prevent substance abuse


summary

Introduced
03/29/2021
In Committee
03/29/2021
Crossed Over
Passed
Dead
12/31/2022

Introduced Session

192nd General Court

Bill Summary

By Ms. Fiola of Fall River, a petition of Carole A. Fiola and others that the Office of Medicaid be authorized to require laboratories providing toxicology testing to demonstrate functional and operational test-utilization and test-frequency control programs. Public Health.

AI Summary

This bill aims to reduce fraud in prescription drug abuse testing and help prevent substance abuse. It authorizes the Office of Medicaid to require laboratories providing toxicology testing to demonstrate functional and operational test-utilization and test-frequency control programs to ensure compliance with MassHealth's requirements. The bill also allows out-of-state independent clinical laboratories that are CLIA-licensed, CAP-accredited, and CLEP-accredited to participate as MassHealth fee-for-service providers and receive payment for clinical toxicology testing, provided they deliver test results to the referring health care provider within two business days of receiving the test specimen.

Committee Categories

Health and Social Services

Sponsors (8)

Last Action

Accompanied a study order, see H5197 (on 09/06/2022)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...